These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7664344)

  • 41. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
    Matsumura M; Fremont DH; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A yeast display system for engineering functional peptide-MHC complexes.
    Brophy SE; Holler PD; Kranz DM
    J Immunol Methods; 2003 Jan; 272(1-2):235-46. PubMed ID: 12505727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenic peptide binding by class I and class II histocompatibility proteins.
    Stern LJ; Wiley DC
    Structure; 1994 Apr; 2(4):245-51. PubMed ID: 8087551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent.
    Tvinnereim A; Wizel B
    J Immunol; 2007 Sep; 179(6):3947-57. PubMed ID: 17785832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design.
    Apostolopoulos V; McKenzie IF; Wilson IA
    Front Biosci; 2001 Oct; 6():D1311-20. PubMed ID: 11578952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligand Design for Specific MHC Class I Molecules on the Cell Surface.
    Sun X; Tokunaga R; Nagai Y; Miyahara R; Kishimura A; Kawakami S; Katayama Y; Mori T
    Biochemistry; 2020 Dec; 59(49):4646-4653. PubMed ID: 33252220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.
    Qu Z; Li Z; Ma L; Wei X; Zhang L; Liang R; Meng G; Zhang N; Xia C
    J Immunol; 2019 Jun; 202(12):3493-3506. PubMed ID: 31076531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3.
    Dabhi VM; Lindahl KF
    Eur J Immunol; 1998 Nov; 28(11):3773-82. PubMed ID: 9842920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E.
    O'Callaghan CA; Tormo J; Willcox BE; Blundell CD; Jakobsen BK; Stuart DI; McMichael AJ; Bell JI; Jones EY
    Protein Sci; 1998 May; 7(5):1264-6. PubMed ID: 9605335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries.
    Stevens J; Wiesmüller KH; Walden P; Joly E
    Eur J Immunol; 1998 Apr; 28(4):1272-9. PubMed ID: 9565367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation.
    Young AC; Nathenson SG; Sacchettini JC
    FASEB J; 1995 Jan; 9(1):26-36. PubMed ID: 7821756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.
    Smith KJ; Reid SW; Stuart DI; McMichael AJ; Jones EY; Bell JI
    Immunity; 1996 Mar; 4(3):203-13. PubMed ID: 8624811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2.
    Urvater JA; Hickman H; Dzuris JL; Prilliman K; Allen TM; Schwartz KJ; Lorentzen D; Shufflebotham C; Collins EJ; Neiffer DL; Raphael B; Hildebrand W; Sette A; Watkins DI
    J Immunol; 2001 Mar; 166(5):3334-44. PubMed ID: 11207289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. H2-M3 presents a nonformylated viral epitope to CTLs generated in vitro.
    Byers DE; Fischer Lindahl K
    J Immunol; 1998 Jul; 161(1):90-6. PubMed ID: 9647211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
    Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
    Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.